Advanced expert playbook for high risk WHO Prequalification & Global Health Agency Audits inspections (guide 11)


Published on 09/12/2025

Advanced Expert Playbook for High Risk WHO Prequalification & Global Health Agency Audits Inspections

In the complex world of biologics and vaccine production, achieving compliance with WHO prequalification (PQ) standards is pivotal for global health suppliers. This expert playbook offers a comprehensive step-by-step guide for preparing for WHO PQ inspections and audits by global health agencies. The primary focus is on ensuring readiness through thorough understanding and implementation of effective processes.

1. Understanding WHO PQ and Its Importance

WHO prequalification is an assessment process that evaluates the quality of health products, including vaccines, to ensure they meet international standards before being used in

public health initiatives. These health products must align not only with WHO regulations but also with regulations from various global health agencies such as FDA, EMA, and others. The primary goal of WHO PQ is to facilitate access to safe and effective medicines for low-income countries, thereby maximizing global health outcomes.

Achieving PQ status is essential for manufacturers aiming to participate in global tenders and supply vaccines for programs run by UNICEF and other Non-Governmental Organizations (NGOs). The process of attaining WHO PQ introduces significant scrutiny into the manufacturing processes, quality control systems, and the overall governance of the product lifecycle.

2. Preparing for WHO PQ Inspections

Preparation for WHO PQ inspections should commence well in advance of the actual audit. This preparation phase encompasses several critical components:

  • Regulatory Knowledge: Familiarize yourself with the WHO guidelines and the specific requirements for your product. The WHO Prequalification program offers detailed requirements that manufacturers should carefully study.
  • Incremental Readiness Assessments: Conduct internal assessments to evaluate compliance at various stages of the manufacturing and quality assurance processes.
  • Training and Development: Invest in training programs for employees involved in quality management, documentation, and compliance activities.
See also  Patient and product risk considerations shaping WHO Prequalification & Global Health Agency Audits priorities

Implementing a structured approach to learning about regulatory requirements will help mitigate the risk of findings during the audit phases.

3. Key Components of a WHO PQ Audit Readiness Plan

Establishing a comprehensive audit readiness plan is crucial for successful WHO PQ inspections. Below are essential components that should be included in any readiness plan:

3.1 Documentation Management

Efficient documentation management is at the core of audit readiness. All essential documentation, including Standard Operating Procedures (SOPs), batch records, and quality assurance records, must be meticulously maintained and easily accessible:

  • Document Control: Implement a robust document control system that assures all documents are version-controlled and up-to-date.
  • Retention Policies: Ensure that retention policies align with regulatory requirements and company policies, maintaining critical documents for appropriate timeframes.
  • Review and Audit of Documents: Conduct regular internal audits of documentation to ensure accuracy and compliance with established guidelines.

3.2 Quality Management System (QMS)

A well-structured QMS underpins compliance and operational excellence. When preparing for audits, your QMS should cover:

  • Risk Management: Employ risk management protocols to identify, evaluate, and mitigate potential risks associated with manufacturing and quality assurance processes.
  • CAPA Programs: A robust Corrective and Preventive Action (CAPA) program is essential for addressing deficiencies identified during internal audits and inspections. Establish mechanisms for tracking CAPA activities to ensure compliance.
  • Annual Product Reviews: These reviews should be part of the continuous quality improvement strategy and reviewed for effectiveness regularly.

4. Conducting Mock Inspections

Mock inspections are a valuable tool that can identify compliance gaps before the official WHO PQ audit. The following steps help conduct effective mock inspections:

  • Assemble an Internal Audit Team: Create a team comprising various departmental representatives who understand the processes and regulations applicable to your product.
  • Establish Audit Criteria: Define specific criteria based on WHO PQ guidelines and other relevant regulations that the mock inspection will cover.
  • Simulate Audit Conditions: Conduct the inspections in a manner that mirrors the conditions expected during an actual audit. Gather data, observe practices, and interview staff to simulate the experience accurately.
  • Document Findings: Record any observations or findings and categorize them according to severity. Develop action plans to address the issues identified.
See also  Using dashboards and quality metrics to monitor WHO Prequalification & Global Health Agency Audits readiness trends

5. Addressing Findings and Continuous Improvement

Once mock inspections and internal audits are completed, it’s imperative to address any findings promptly. Here’s how:

  • Prioritize Issues: Classify findings based on their potential impact on product quality and patient safety, addressing critical issues immediately.
  • Implement Corrective Actions: Develop a clear action plan that lays out how each issue will be resolved. Track the implementation of these actions to ensure accountability.
  • Review and Refine Processes: Continuous improvement should be ingrained in your company’s culture, encouraging regular reviews and updates to systems and processes.

By nurturing a culture of continuous improvement within your organization, you can enhance compliance and minimize the risk of non-conformance during WHO PQ inspections.

6. Global Agency Audits Beyond WHO PQ

In addition to WHO PQ inspections, it is crucial to remain vigilant regarding audits conducted by other global health agencies and regulatory bodies. This encompasses understanding audit protocols established by the FDA, EMA, and other regulatory authorities. Key considerations include:

  • Regulatory Landscape: Keep abreast of evolving global regulations and standards, particularly concerning biologics and vaccines.
  • Unified Quality Standards: Strive for standardized processes across all regions where you operate to facilitate smoother audits across different jurisdictions.
  • Engagement with Regulatory Bodies: Proactively engage with inspectors from various agencies to understand their specific expectations during audits.

7. Final Preparations for Audits

As the audit date approaches, ensure that all preparations are finalized by executing the following checklists:

  • Documentation Check: Verify that all required documents are compiled and readily available for review.
  • Employee Readiness: Conduct pre-audit training sessions to ensure staff understand their roles and responsibilities during the inspection.
  • Facility Readiness: Ensure that all manufacturing areas comply with cleanliness, organization, and safety protocols as per regulatory requirements.
  • Prepare for Interviews: Schedule mock interviews to better prepare personnel for actual interactions with auditors.

8. Conclusion

Successfully navigating WHO prequalification and global health agency audits requires diligent preparation, a strong quality management system, and a culture of continuous improvement. By adhering to the outlined step-by-step processes and engaging staff at all levels, organizations can ensure compliance with regulatory requirements and increase their chances of successfully passing inspections.

See also  How to select the right CDMO partner and contract model for deviations, failures & cross-site troubleshooting (commercial guide 7)

For manufacturers seeking to maintain a competitive edge in the market, implementing these strategies will yield not only regulatory success but also enhance product quality and ultimately, patient safety. Consistent readiness and proactive measures are vital ingredients for achieving WHO PQ status and securing opportunities in global health initiatives.